共 4 条
- [1] EXPRESSION OF THE RAT L-TYPE PYRUVATE-KINASE GENE FROM ITS DUAL ERYTHROID-SPECIFIC AND LIVER-SPECIFIC PROMOTER IN TRANSGENIC MICEJOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (33) : 19904 - 19910TREMP, GLBOQUET, DRIPOCHE, MACOGNET, MLONE, YCJAMI, JKAHN, ADAEGELEN, D
- [2] Transactivation of the L-PK TATA components by the SV40 viral enhancer-binding proteins requires HNF-1 a in HepG2 and HEK293 cells and its application for generating expression vectors active in HNF-1 a - Expressing cells used for liver gene therapyMOLECULAR THERAPY, 2003, 7 (05) : S379 - S379Park, CWPark, YMLee, GTJun, SLee, HCWoo, S
- [3] Development of AAV2/8-Mediated Gene Therapy Clinical Trial for Crigler-Najjar Syndrome Type I: Optimization of Liver-Specific Expression CassetteMOLECULAR THERAPY, 2013, 21 : S192 - S193Pastore, NunziaAuricchio, AlbertoBrunetti-Pierri, Nicola
- [4] Differential transactivation by HNF-1a of the L-PK proximal promoter depending on the cell type of HNF-1a producing cells and use of multimer binding sites of HNF-1a for generation of a gene therapy-oriented expression vector in the pancreatic B cellsMOLECULAR THERAPY, 2003, 7 (05) : S380 - S380Park, YMLee, GTJun, SPark, CWWoo, SLee, HC